CLINICAL_TRIALS
trial_result
· 2020-09-24
Clinical Trial Update: Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas [Phase 2]
Summary
Phase 2 trial evaluating enzastaurin with bevacizumab in recurrent glioblastoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Recurrent Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2020-09-24